Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸¸¼º¸²ÇÁ±¸¼º¹éÇ÷º´ÀÇ ÀÓ»óÀû °íÂû A Clinical Study on Patients with Chronic Lymphocytic Leukemia

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 6È£ p.1106 ~ 1113
¼Ò¼Ó »ó¼¼Á¤º¸
¾çÀüÈ£/Jeon Ho Yang ½ÅÇö¼ö/Á¤¿µ½Ä/ȲÁØÈ£/½Åµ¿°Ç/¼Õ»ó±Õ/À̱Ժ¸/Ȳ±â¼®/Hyeon Soo Shin/Young Sik Jung/Jun Ho Whang/Dong Gun Shin/Sang Kyun Sohn/Kyu Bo Lee/Kee Suk Whang

Abstract

¼­·Ð
¸¸¼º¸²ÇÁ±¸¼º¹éÇ÷º´(Chronic lymphocytic leukemia, CLL) Àº Ç÷¾×, °ñ¼ö, ÀÓÆļ±, ºñÀå µî
¿¡¼­ÀÇ ¾Ç¼º B ¸²ÇÁ±¸ÀÇ Å¬·Ð¼º Áõ½Ä°ú ÃàÀûÀ» Ư¡À¸·Î ÇÏ¸ç ¼­±¸¿¡¼­´Â °¡Àå ÈçÇÑ ¹éÇ÷
º´ÀÇ ÇÑ ÇüÅÂÀ̳ª ±¹³»¿¡¼­´Â ¹éÇ÷º´ ȯÀÚ Áß 0.4¡­1.7% ¸¸À» Â÷ÁöÇÏ´Â ºñ±³Àû µå¹® ÁúȯÀ¸
·Î º¸°íµÇ°í ÀÖ´Ù.
CLLÀº ´Ù¾çÇÑ ÀÓ»óÁõ»ó ¹× °æ°ú¸¦ ÃëÇÏ´Â ÁúȯÀ¸·Î ÃÖ±Ù ¼­±¸¿¡¼­´Â CLL¿¡ ´ëÇÑ »ý¹°
ÇÐ, ÀÚ¿¬°æ°ú, Ä¡·á¿¡ ´ëÇÑ ¸¹Àº ¹ßÀüÀÌ ÀÖ¾î¿ÔÀ¸³ª ±¹³»¿¡¼­´Â ÀûÀº ¼öÀÇ È¯ÀÚ·Î ÀÎÇÏ¿© Æ÷
°ýÀûÀÎ ¿¬±¸°¡ ¾ø´Â »óÅÂÀÌ´Ù. ÀÌ¿¡ ÀúÀÚµéÀº ¸»ÃÊÇ÷¾×µµ¸» ¹× °ñ¼ö»ý°Ë¿¡ ÀÇÇØ CLL·Î Áø
´Ü ¹ÞÀº 17¿¹¸¦ ´ë»óÀ¸·Î ÀÓ»ó»óÀ» ºÐ¼®ÇÏ¿© ¼­±¸ÀÇ °æ¿ì¿Í ºñ±³, °ËÅäÇÏ¿© ¹®Çå°íÂû°ú ÇÔ
²² º¸°íÇÏ´Â ¹ÙÀÌ´Ù.
#ÃÊ·Ï#
Purpose : Chronic lymphocytic leukemia(CLL) is the most common form of leukemia
in western countries but it has been reported rarely in Korea. The purpose of this study
was to evaluate the clinical characteristics, treatment responses and prognosis of the
patients with CLL.
Materials and Methods : We retrospectively reviewed the medical records of 17
patients with CLL diagnosed at the Catholic University of Taegu-Hyosung &
Kyungpook National University Hospital from Jan. 1986 to Mar. 1996.
Results : There were 9 males and 8 females and the mean age was 55 years. The
majority of patients had systemic symptoms(77%) and advanced clinical stage(Binet
stage C, 70%) at the time of diagnosis. The bone marrow histology was reviewed in 13
cases and patients were subdivided into those with a diffuse(9cases) and
nondiffuse(4cases) pattern of bone marrow histology. In patients with advanced clinical
stage, diffuse pattern was predominated and showed poor survival. 14 patients were
treated with chlorambucil/steroid or combination chemotherapy. Among the 13 evaluable
patients, 1(8%) achieved a complete response and 7(54%) achieved partial responses, and
median survival duration was 18months. 11 patients died after 2¡­18 months of
follow-up and infection was the main cause of death.
Conclusion : Poor prognostic factors, such as high blood lymphocyte counts, diffuse
bone marrow involvement pattern & advanced clinical stage, are common in our patients
at presentation 6: showed poor survival.

Å°¿öµå

Chronic lymphocytic leukemia;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS